Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck by James Thorne on September 16, 2019September 16, 2019 at 9:34 am Danish drugmaker Lundbeck is set to buy Bothell, Wash.-based Alder Biopharmaceuticals in a deal that could be worth up to $1.95 billion, sending Alder’s stock rocketing up 83 percent on… Read More